The FDA has announced that yoghurt manufacturers can now make claims suggesting that consuming their dairy products may lower the risk of type 2 diabetes, citing “limited evidence.” This decision allows companies to assert that consuming at least two cups of yoghurt per week could potentially decrease a person’s likelihood of developing the disease, which affects an estimated 36 million Americans.
Danone had initially requested the FDA issue this “qualified health claim” in 2018, prompted by a growing body of research indicating a potential link between yoghurt consumption and type 2 diabetes. Following the FDA’s decision, all dairy-based yoghurt producers, including competitors like Chobani and Yoplait maker General Mills, are now permitted to use this claim on their products.
While acknowledging “some credible evidence” supporting the relationship between yoghurt consumption and reduced diabetes risk, the FDA highlighted that it wasn’t attributable to any specific nutrient or compound. Additionally, the agency expressed concerns regarding the use of such claims on yoghurts with significant amounts of added sugar, cautioning against potential contributions to empty calories.
Despite these considerations, the FDA’s endorsement of the link between yoghurt and diabetes risk reduction could prove highly lucrative for food and beverage manufacturers seeking to boost their product consumption. This support from the government agency mirrors other labelling certifications seen on food products, such as the American Heart Association’s “Heart-Check mark certification.”
Danone, known for yoghurts like Oikos, Two Good, and Activia, expressed optimism about the FDA’s decision. The company sees potential for yoghurt to become a preferred choice for consumers aiming to lower their diabetes risk, providing another compelling reason for shoppers to explore the yoghurt aisle.
Miguel Freitas, Vice President of Health and Scientific Affairs at Danone, welcomed the announcement, stating, “Our hope is that this announcement will empower consumers with simple, actionable information they can use to help lower their risk of developing type 2 diabetes through a realistic, easy-to-make dietary modification.”
The FDA’s decision to issue qualified health claims for various foods, including yoghurt, aligns with previous actions such as endorsing cocoa flavanols and cranberry products for their potential health benefits, reflecting the agency’s ongoing efforts to provide consumers with informative dietary guidance.